Proteomics in cardiology: research and practice

Area of Science:

• Cardiology
• Proteomics
• Epidemiology

Background:

• Cardiovascular disease (CVD) is a major global cause of death, with known risk factors not fully explaining disease variations.
• Understanding the biological mechanisms and causal relevance of CVD risk factors requires further investigation.

Purpose of the Study:

• To review the role of proteomics in advancing cardiovascular medicine.
• To highlight the utility of blood protein quantification in risk prediction, diagnosis, patient stratification, and understanding CVD pathophysiology.
• To identify potential therapeutic targets for cardiovascular conditions.

Main Methods:

• Review of recent findings from large population-based epidemiological and clinical studies.
• Application of high-throughput affinity-based proteomic assays for quantifying thousands of blood protein markers.

Main Results:

• Proteomics enables improved cardiovascular risk prediction, diagnosis, and patient stratification.
• Proteomic data aids in understanding the etiology and pathophysiology of cardiovascular diseases.
• Proteomics facilitates the identification of novel and repurposed therapeutic targets for CVD.

Conclusions:

• Proteomics is a valuable tool for precision cardiovascular medicine, offering insights into disease mechanisms and treatment strategies.
• Future research requires larger sample sizes, diverse populations, and longitudinal proteomic data for clinical translation.
• Continued advancements in proteomics will transform the development of personalized cardiology globally.